4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001179110-15-003044
CIK 0001274792operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:14 PM ET
Size
8.6 KB
Accession
0001179110-15-003044
Insider Transaction Report
Form 4
Mulroy Robert J.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2015-02-20$1.71/sh+150,000$256,500→ 1,489,316 total - Sale
Common Stock
2015-02-20$10.94/sh−150,000$1,641,000→ 1,339,316 total - Exercise/Conversion
Stock Option (right to buy)
2015-02-20−150,000→ 306,753 totalExercise: $1.71Exp: 2015-08-03→ Common Stock (150,000 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.73 to $11.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]This option is fully vested.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:14 PM ET
- Size
- 8.6 KB